Veterynarna biotehnologija – Veterinary biotechnology, 2016, 29, 278-284 [in English].
RIEZNICHENKO L.S., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it., DYBKOVA S.M., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it., GRUZINA Т.G., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
F.D. Ovcharenko Institute of Biocolloidal Chemistry NASU, Institute of Veterinary Medicine NAAS
RYZHENKO G.F., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it., GORBATYUK O.I., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it., ANDRIYASCHUK V.A., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it., ZHOVNIR O.M., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Institute of Veterinary Medicine NAAS
EXPERIMENTAL BISMUTH NANOPARTICLES: ANTIMICROBIAL EFFECTIVENESS AND BIOSAFETY LEVEL
The article presents results of antimicrobial effectiveness estimation in vitro and biosafety level control in vitro and in vivo for experimental substance of spherical 40 nm bismuth nanoparticles. High bactericidal effectiveness against wide spectra of pathogen microorganisms – potential causative agents of livestock and poultry infectious diseases has been revealed for the analyzed nanoparticles as well as biosafety according to the analyzed parameters of genotoxicity, cytotoxicity, mutagenisity and acute toxicity LD50.
Keywords: Bismuth nanoparticles, antimicrobial activity, pathogen test-strains, effectiveness, biosafety level.
REFERENCES